Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric R James

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
The American Journal of Tropical Medicine and Hygiene|June 27, 2018
Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of <i>Plasmodium falciparum</i> Sporozoite Vaccine in Tanzanian AdultsSaid A Jongo, Seif A Shekalaghe, L W Preston Church, et al.
The American Journal of Tropical Medicine and Hygiene|April 18, 2019
Safety and Differential Antibody and T-Cell Responses to the <i>Plasmodium falciparum</i> Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and InfantsSaid A Jongo, L W Preston Church, Ali T Mtoro, et al.
Nature Medicine|January 6, 2026
Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trialMelissa C Kapulu, Francesca Orenge, Domtila Kimani, et al.
The Lancet. Infectious Diseases|February 21, 2017
Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trialMahamadou S Sissoko, Sara A Healy, Abdoulaye Katile, et al.
Nature|July 1, 2021
Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunityAgnes Mwakingwe-Omari, Sara A Healy, Jacquelyn Lane, et al.
EMBO Molecular Medicine|September 29, 2025
Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanilSteffen Borrmann, Zita Sulyok, Katja Müller, et al.
Nature Communications|September 22, 2019
Plasmodium vivax chloroquine resistance links to pvcrt transcription in a genetic crossJuliana M Sá, Sarah R Kaslow, Roberto R Moraes Barros, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2017
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infectionKirsten E Lyke, Andrew S Ishizuka, Andrea A Berry, et al.
JCI Insight|January 19, 2017
Protection against <i>Plasmodium falciparum</i> malaria by PfSPZ VaccineJudith E Epstein, Kristopher M Paolino, Thomas L Richie, et al.
The American Journal of Tropical Medicine and Hygiene|November 18, 2020
Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean AdultsSaid A Jongo, Vicente Urbano, L W Preston Church, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The American Journal of Tropical Medicine and Hygiene|June 27, 2018
Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of <i>Plasmodium falciparum</i> Sporozoite Vaccine in Tanzanian AdultsSaid A Jongo, Seif A Shekalaghe, L W Preston Church, et al.
The American Journal of Tropical Medicine and Hygiene|April 18, 2019
Safety and Differential Antibody and T-Cell Responses to the <i>Plasmodium falciparum</i> Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and InfantsSaid A Jongo, L W Preston Church, Ali T Mtoro, et al.
Nature Medicine|January 6, 2026
Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trialMelissa C Kapulu, Francesca Orenge, Domtila Kimani, et al.
The Lancet. Infectious Diseases|February 21, 2017
Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trialMahamadou S Sissoko, Sara A Healy, Abdoulaye Katile, et al.
Nature|July 1, 2021
Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunityAgnes Mwakingwe-Omari, Sara A Healy, Jacquelyn Lane, et al.
EMBO Molecular Medicine|September 29, 2025
Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanilSteffen Borrmann, Zita Sulyok, Katja Müller, et al.
Nature Communications|September 22, 2019
Plasmodium vivax chloroquine resistance links to pvcrt transcription in a genetic crossJuliana M Sá, Sarah R Kaslow, Roberto R Moraes Barros, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2017
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infectionKirsten E Lyke, Andrew S Ishizuka, Andrea A Berry, et al.
JCI Insight|January 19, 2017
Protection against <i>Plasmodium falciparum</i> malaria by PfSPZ VaccineJudith E Epstein, Kristopher M Paolino, Thomas L Richie, et al.
The American Journal of Tropical Medicine and Hygiene|November 18, 2020
Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean AdultsSaid A Jongo, Vicente Urbano, L W Preston Church, et al.
Pageof 6